Nath Bio-Genes India Ltd Q1FY22 net profit at Rs. 44.91 crore

Nath Bio-Genes India Ltd. has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.215.10 crores during the period ended June 30, 2021 as compared to Rs.54.91 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.44.91 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.7.14 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.23.63 for the period ended June 30, 2021 as compared to Rs.3.76 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 215.10 crs	₹ 54.91 crs	291.73%
Net Profit	₹ 44.91 crs	₹ 7.14 crs	528.99%
EPS	₹ 23.63	₹ 3.76	528.46%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.215.10 crores during the period ended June 30, 2021 as compared to Rs.193.64 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.44.91 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.41.25 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.23.63 for the period ended June 30, 2021 as compared to Rs.21.71 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 215.10 crs	₹ 193.64 crs	11.08%
Net Profit	₹ 44.91 crs	₹ 41.25 crs	8.87%
EPS	₹ 23.63	₹ 21.71	8.84%

Shares of Nath Bio-Genes India Ltd. was last trading in BSE at Rs. 362.15 as compared to the previous close of Rs. 375.45. The total number of shares traded during the day was 5608 in over 696 trades.

The stock hit an intraday high of Rs. 376.85 and intraday low of 342.45. The net turnover during the day was Rs. 2043029.

Source : Equity Bulls

Keywords